ARMISTICE CAPITAL, LLC historic quarter change: USA Other Stocks, Reduced
In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 17 quarters from 2014-12-31 to 2026-06-30, ARMISTICE CAPITAL, LLC opened 185 positions, added to 131, reduced 90 and sold out of 256.
- Q2 2025: Stock CALIDI BIOTHERAPEUTICS INC; Country of operation United States; Class COM NEW; Shares before 3,322,000.
- Q2 2025: Stock MACKENZIE RLTY CAP INC; Country of operation United States; Class COM; Shares before 1,445,735.
- Q2 2025: Stock ROCKWELL MED INC; Country of operation United States; Class COM NEW; Shares before 2,366,144.
- Q2 2025: Stock SPHERE 3D CORP NEW; Country of operation —; Class COM NEW; Shares before 2,204,934.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1601086), 17 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-17); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2014-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q2 2025 | CALIDI BIOTHERAPEUTICS INC
CUSIP 320703309 | United States | COM NEW | 3,322,000 | 792,000 | -2,530,000 | $1,880,916 | $182,160 | -$1,698,756 | 2025-08-14 |
|---|
| Q2 2025 | MACKENZIE RLTY CAP INC
CUSIP 55453W105 | United States | COM | 1,445,735 | 1,243,735 | -202,000 | $2,168,603 | $833,302 | -$1,335,301 | 2025-08-14 |
|---|
| Q2 2025 | ROCKWELL MED INC
CUSIP 774374300 | United States | COM NEW | 2,366,144 | 2,149,471 | -216,673 | $2,673,743 | $1,822,751 | -$850,992 | 2025-08-14 |
|---|
| Q2 2025 | SPHERE 3D CORP NEW
CUSIP 84841L407 | | COM NEW | 2,204,934 | 1,996,000 | -208,934 | $878,666 | $1,177,840 | +$299,174 | 2025-08-14 |
|---|
| Q2 2025 | DERMATA THERAPEUTICS INC
CUSIP 249845405 | United States | COM | 411,000 | 322,179 | -88,821 | $443,880 | $188,475 | -$255,405 | 2025-08-14 |
|---|
| Q1 2025 | SCILEX HOLDING CO
CUSIP 80880W106 | | COM | 17,877,376 | 13,792,000 | -4,085,376 | $7,622,913 | $3,427,312 | -$4,195,601 | 2025-05-15 |
|---|
| Q1 2025 | ROCKWELL MED INC
CUSIP 774374300 | United States | COM NEW | 3,043,678 | 2,366,144 | -677,534 | $6,209,103 | $2,673,743 | -$3,535,360 | 2025-05-15 |
|---|
| Q1 2025 | VERRICA PHARMACEUTICALS INC
CUSIP 92511W108 | United States | COM | 8,921,000 | 8,567,400 | -353,600 | $6,244,700 | $3,788,504 | -$2,456,196 | 2025-05-15 |
|---|
| Q1 2025 | PALATIN TECHNOLOGIES INC
CUSIP 696077502 | United States | COM NEW | 1,992,826 | 1,671,595 | -321,231 | $2,212,037 | $974,373 | -$1,237,664 | 2025-05-15 |
|---|
| Q1 2025 | ACCELERATE DIAGNOSTICS INC
CUSIP 00430H201 | United States | COM NEW | 2,078,000 | 1,879,227 | -198,773 | $2,493,600 | $1,317,338 | -$1,176,262 | 2025-05-15 |
|---|
| Q1 2025 | METAVIA INC
CUSIP 64132R404 | United States | COM | 728,637 | 525,605 | -203,032 | $1,479,133 | $809,432 | -$669,701 | 2025-05-15 |
|---|
| Q1 2025 | VOLITIONRX LTD
CUSIP 928661107 | United States | COM | 8,481,895 | 8,206,430 | -275,465 | $5,089,137 | $4,678,486 | -$410,651 | 2025-05-15 |
|---|
| Q1 2025 | LM FDG AMER INC
CUSIP 502074503 | United States | COM NEW | 368,000 | 309,994 | -58,006 | $791,200 | $384,393 | -$406,807 | 2025-05-15 |
|---|
| Q1 2025 | INTENSITY THERAPEUTICS INC
CUSIP 45828J103 | United States | COM | 1,126,868 | 872,547 | -254,321 | $1,983,288 | $1,718,918 | -$264,370 | 2025-05-15 |
|---|
| Q1 2025 | SHUTTLE PHARMACTCLS HLDGS IN
CUSIP 825693302 | United States | COM NEW | 306,057 | 70,399 | -235,658 | $262,903 | $27,385 | -$235,518 | 2025-05-15 |
|---|
| Q4 2024 | ROCKWELL MED INC
CUSIP 774374300 | United States | COM NEW | 3,581,525 | 3,043,678 | -537,847 | $14,218,654 | $6,209,103 | -$8,009,551 | 2025-02-14 |
|---|
| Q4 2024 | INARI MED INC
CUSIP 45332Y109 | United States | COM | 1,822,000 | 1,565,577 | -256,423 | $75,139,280 | $79,922,706 | +$4,783,426 | 2025-02-14 |
|---|
| Q4 2024 | REVIVA PHARMACEUTCLS HLDGS I
CUSIP 76152G100 | United States | COM | 3,186,000 | 1,364,000 | -1,822,000 | $4,587,840 | $2,468,840 | -$2,119,000 | 2025-02-14 |
|---|
| Q4 2024 | VINCERX PHARMA INC
CUSIP 92731L106 | United States | COM NEW | 2,704,000 | 567,011 | -2,136,989 | $1,936,064 | $149,010 | -$1,787,054 | 2025-02-14 |
|---|
| Q4 2024 | ALLURION TECHNOLOGIES INC
CUSIP 02008G102 | United States | COM SHS | 7,806,000 | 7,527,400 | -278,600 | $4,785,078 | $3,236,782 | -$1,548,296 | 2025-02-14 |
|---|
| Q4 2024 | EKSO BIONICS HLDGS INC
CUSIP 282644301 | United States | COM | 2,167,000 | 1,725,649 | -441,351 | $2,513,720 | $1,052,646 | -$1,461,074 | 2025-02-14 |
|---|
| Q4 2024 | METAVIA INC
CUSIP 64132R404 | United States | COM | 848,000 | 728,637 | -119,363 | $2,688,160 | $1,479,133 | -$1,209,027 | 2025-02-14 |
|---|
| Q4 2024 | ACCELERATE DIAGNOSTICS INC
CUSIP 00430H201 | United States | COM NEW | 2,101,000 | 2,078,000 | -23,000 | $3,592,710 | $2,493,600 | -$1,099,110 | 2025-02-14 |
|---|
| Q4 2024 | VOLITIONRX LTD
CUSIP 928661107 | United States | COM | 8,998,727 | 8,481,895 | -516,832 | $5,408,235 | $5,089,137 | -$319,098 | 2025-02-14 |
|---|
| Q4 2024 | 5E ADVANCED MATERIALS INC
CUSIP 33830Q109 | United States | COMMON STOCK | 4,980,000 | 4,006,784 | -973,216 | $2,689,200 | $2,564,342 | -$124,858 | 2025-02-14 |
|---|
| Q4 2024 | NANOVIBRONIX INC
CUSIP 63008J603 | United States | COM NEW | 278,708 | 189,300 | -89,408 | $170,569 | $111,687 | -$58,882 | 2025-02-14 |
|---|
| Q3 2024 | SCILEX HOLDING CO
CUSIP 80880W106 | | COM | 11,950,000 | 3,510,000 | -8,440,000 | $23,063,500 | $3,245,346 | -$19,818,154 | 2024-11-14 |
|---|
| Q3 2024 | FIBROGEN INC
CUSIP 31572Q808 | United States | COM | 8,936,000 | 6,800,000 | -2,136,000 | $7,973,593 | $2,715,920 | -$5,257,673 | 2024-11-14 |
|---|
| Q3 2024 | CITIUS PHARMACEUTICALS INC
CUSIP 17322U207 | United States | COM NEW | 10,156,000 | 7,276,000 | -2,880,000 | $5,928,057 | $3,642,366 | -$2,285,691 | 2024-11-14 |
|---|
| Q3 2024 | BRAINSTORM CELL THERAPEUTICS
CUSIP 10501E201 | United States | COM NEW | 7,917,653 | 6,897,653 | -1,020,000 | $2,680,126 | $1,588,529 | -$1,091,597 | 2024-11-14 |
|---|
| Q3 2024 | P3 HEALTH PARTNERS INC
CUSIP 744413105 | United States | COM CL A | 7,900,000 | 6,650,000 | -1,250,000 | $3,557,370 | $2,568,895 | -$988,475 | 2024-11-14 |
|---|
| Q3 2024 | SAFE & GREEN HOLDINGS CORP
CUSIP 78418A604 | United States | COM NEW | 85,000 | 61,000 | -24,000 | $243,950 | $58,255 | -$185,695 | 2024-11-14 |
|---|
| Q3 2024 | CHIMERIX INC
CUSIP 16934W106 | United States | COM | 2,224,000 | 2,208,000 | -16,000 | $1,948,224 | $2,053,440 | +$105,216 | 2024-11-14 |
|---|
| Q2 2024 | CLEARSIDE BIOMEDICAL INC
CUSIP 185063104 | United States | COM | 3,956,000 | 2,136,000 | -1,820,000 | $6,052,680 | $2,776,800 | -$3,275,880 | 2024-08-14 |
|---|
| Q2 2024 | PORTAGE BIOTECH INC
CUSIP G7185A128 | | COM | 1,665,885 | 1,501,780 | -164,105 | $938,393 | $318,678 | -$619,715 | 2024-08-14 |
|---|
| Q2 2024 | CHIMERIX INC
CUSIP 16934W106 | United States | COM | 2,264,000 | 2,224,000 | -40,000 | $2,399,840 | $1,948,224 | -$451,616 | 2024-08-14 |
|---|
| Q2 2024 | SOL GEL TECHNOLOGIES
CUSIP M8694L103 | | SHS | 2,078,000 | 2,032,000 | -46,000 | $2,036,648 | $1,808,480 | -$228,168 | 2024-08-14 |
|---|
| Q2 2024 | STRONGHOLD DIGITAL MINING IN
CUSIP 86337R202 | United States | CLASS A COM | 1,000,000 | 915,978 | -84,022 | $4,150,000 | $3,929,546 | -$220,454 | 2024-08-14 |
|---|
| Q2 2024 | CHECKPOINT THERAPEUTICS INC
CUSIP 162828206 | United States | COM NEW | 2,716,000 | 2,506,000 | -210,000 | $5,567,800 | $5,387,900 | -$179,900 | 2024-08-14 |
|---|
| Q2 2024 | NANOVIBRONIX INC
CUSIP 63008J603 | United States | COM NEW | 250,899 | 136,894 | -114,005 | $225,809 | $95,826 | -$129,983 | 2024-08-14 |
|---|
| Q2 2024 | GEOVAX LABS INC
CUSIP 373678606 | United States | COM SHS | 178,000 | 80,000 | -98,000 | $356,000 | $254,800 | -$101,200 | 2024-08-14 |
|---|
| Q2 2024 | ACCELERATE DIAGNOSTICS INC
CUSIP 00430H201 | United States | COM NEW | 1,846,000 | 1,608,000 | -238,000 | $1,827,540 | $1,881,360 | +$53,820 | 2024-08-14 |
|---|
| Q2 2024 | CATHETER PRECISION INC
CUSIP 74933X302 | United States | COM | 621,408 | 477,408 | -144,000 | $302,004 | $279,284 | -$22,720 | 2024-08-14 |
|---|
| Q1 2024 | SHOCKWAVE MED INC
CUSIP 82489T104 | United States | COM | 426,057 | 66,169 | -359,888 | $81,189,422 | $21,546,611 | -$59,642,811 | 2024-05-15 |
|---|
| Q1 2024 | TERRAN ORBITAL CORPORATION
CUSIP 88105P103 | United States | COM | 16,300,000 | 3,600,000 | -12,700,000 | $18,582,000 | $4,716,000 | -$13,866,000 | 2024-05-15 |
|---|
| Q1 2024 | FIBROGEN INC
CUSIP 31572Q808 | United States | COM | 9,764,000 | 7,936,000 | -1,828,000 | $8,653,833 | $18,649,600 | +$9,995,767 | 2024-05-15 |
|---|
| Q1 2024 | PARAMOUNT GLOBAL
CUSIP 92556H206 | United States | CLASS B COM | 1,411,300 | 967,308 | -443,992 | $20,873,127 | $11,385,215 | -$9,487,912 | 2024-05-15 |
|---|
| Q1 2024 | SILK RD MED INC
CUSIP 82710M100 | United States | COM | 1,768,000 | 956,000 | -812,000 | $21,693,360 | $17,513,920 | -$4,179,440 | 2024-05-15 |
|---|
| Q1 2024 | PORTAGE BIOTECH INC
CUSIP G7185A128 | | COM | 1,876,105 | 1,665,885 | -210,220 | $3,414,511 | $938,393 | -$2,476,118 | 2024-05-15 |
|---|
| Q1 2024 | RIGEL PHARMACEUTICALS INC
CUSIP 766559603 | United States | COM NEW | 17,100,000 | 15,360,000 | -1,740,000 | $24,795,000 | $22,732,800 | -$2,062,200 | 2024-05-15 |
|---|
| Q1 2024 | COEPTIS THERAPEUTICS HLDGS I
CUSIP 19207A108 | United States | COM | 3,520,000 | 3,030,269 | -489,731 | $2,759,328 | $901,202 | -$1,858,126 | 2024-05-15 |
|---|
| Q1 2024 | TONIX PHARMACEUTICALS HLDG C
CUSIP 890260854 | United States | COM NEW | 3,770,000 | 489,000 | -3,281,000 | $1,519,310 | $90,954 | -$1,428,356 | 2024-05-15 |
|---|
| Q1 2024 | HEPION PHARMACEUTICALS INC
CUSIP 426897302 | United States | COM NEW | 418,000 | 390,000 | -28,000 | $1,354,320 | $971,100 | -$383,220 | 2024-05-15 |
|---|
| Q1 2024 | MUSTANG BIO INC
CUSIP 62818Q203 | United States | COM NEW | 435,764 | 210,000 | -225,764 | $588,281 | $218,400 | -$369,881 | 2024-05-15 |
|---|
| Q1 2024 | SOL GEL TECHNOLOGIES
CUSIP M8694L103 | | SHS | 2,135,000 | 2,078,000 | -57,000 | $2,359,175 | $2,036,648 | -$322,527 | 2024-05-15 |
|---|
| Q1 2024 | PAINREFORM LTD
CUSIP M77798128 | | ORD SHS NEW | 170,000 | 156,000 | -14,000 | $467,500 | $283,920 | -$183,580 | 2024-05-15 |
|---|
| Q1 2024 | CHIMERIX INC
CUSIP 16934W106 | United States | COM | 2,598,000 | 2,264,000 | -334,000 | $2,500,575 | $2,399,840 | -$100,735 | 2024-05-15 |
|---|
| Q1 2024 | SALARIUS PHARMACEUTICALS INC
CUSIP 79400X305 | United States | COM NEW | 88,000 | 84,000 | -4,000 | $57,200 | $44,402 | -$12,798 | 2024-05-15 |
|---|
| Q3 2016 | TAILORED BRANDS INC
CUSIP 87403A107 | | COM | 688,000 | 214,000 | -474,000 | $8,710,000 | $3,360,000 | -$5,350,000 | 2016-11-14 |
|---|
| Q3 2016 | ANTARES PHARMA INC
CUSIP 036642106 | | COM | 15,430,000 | 12,300,000 | -3,130,000 | $16,202,000 | $20,664,000 | +$4,462,000 | 2016-11-14 |
|---|
| Q3 2016 | BUFFALO WILD WINGS INC
CUSIP 119848109 | | COM | 56,000 | 40,000 | -16,000 | $7,781,000 | $5,630,000 | -$2,151,000 | 2016-11-14 |
|---|
| Q3 2016 | SYNERGY PHARMACEUTICALS DEL
CUSIP 871639308 | United States | COM NEW | 1,330,000 | 1,240,000 | -90,000 | $5,054,000 | $6,832,000 | +$1,778,000 | 2016-11-14 |
|---|
| Q3 2016 | IGNYTA INC
CUSIP 451731103 | | COM | 1,556,000 | 1,464,000 | -92,000 | $8,434,000 | $9,209,000 | +$775,000 | 2016-11-14 |
|---|
| Q3 2016 | TENAX THERAPEUTICS INC
CUSIP 88032L100 | | COM | 1,110,000 | 1,068,000 | -42,000 | $2,842,000 | $2,472,000 | -$370,000 | 2016-11-14 |
|---|
| Q2 2016 | BLUCORA INC
CUSIP 095229100 | United States | COM | 1,908,000 | 500,000 | -1,408,000 | $9,845,000 | $5,180,000 | -$4,665,000 | 2016-08-15 |
|---|
| Q2 2016 | AEGERION PHARMACEUTICALS INC
CUSIP 00767E102 | | COM | 1,498,000 | 800,000 | -698,000 | $5,543,000 | $1,192,000 | -$4,351,000 | 2016-08-15 |
|---|
| Q2 2016 | ACORDA THERAPEUTICS INC
CUSIP 00484M106 | | COM | 358,000 | 232,000 | -126,000 | $9,469,000 | $5,917,000 | -$3,552,000 | 2016-08-15 |
|---|
| Q2 2016 | IGNYTA INC
CUSIP 451731103 | | COM | 1,688,000 | 1,556,000 | -132,000 | $11,428,000 | $8,434,000 | -$2,994,000 | 2016-08-15 |
|---|
| Q2 2016 | BIODELIVERY SCIENCES
CUSIP 09060J106 | | COM | 2,712,000 | 2,652,000 | -60,000 | $8,760,000 | $6,259,000 | -$2,501,000 | 2016-08-15 |
|---|
| Q2 2016 | DEMAND MEDIA INC
CUSIP 24802N208 | | COM NEW | 1,096,000 | 720,000 | -376,000 | $5,480,000 | $3,722,000 | -$1,758,000 | 2016-08-15 |
|---|
| Q2 2016 | SYNERGY PHARMACEUTICALS DEL
CUSIP 871639308 | United States | COM NEW | 2,200,000 | 1,330,000 | -870,000 | $6,072,000 | $5,054,000 | -$1,018,000 | 2016-08-15 |
|---|
| Q2 2016 | TENAX THERAPEUTICS INC
CUSIP 88032L100 | | COM | 1,170,000 | 1,110,000 | -60,000 | $2,399,000 | $2,842,000 | +$443,000 | 2016-08-15 |
|---|
| Q1 2016 | SPECTRANETICS CORP
CUSIP 84760C107 | | COM | 586,000 | 172,000 | -414,000 | $8,825,000 | $2,497,000 | -$6,328,000 | 2016-05-16 |
|---|
| Q1 2016 | DEMAND MEDIA INC
CUSIP 24802N208 | | COM NEW | 1,156,000 | 1,096,000 | -60,000 | $6,358,000 | $5,480,000 | -$878,000 | 2016-05-16 |
|---|
| Q1 2016 | KATE SPADE & CO
CUSIP 485865109 | | COM | 340,000 | 224,000 | -116,000 | $6,042,000 | $5,716,000 | -$326,000 | 2016-05-16 |
|---|
| Q4 2015 | XENOPORT INC
CUSIP 98411C100 | | COM | 3,330,000 | 1,080,000 | -2,250,000 | $11,555,000 | $5,929,000 | -$5,626,000 | 2016-02-16 |
|---|
| Q4 2015 | THERAVANCE BIOPHARMA INC
CUSIP 88338T104 | | COM | 1,341,000 | 750,000 | -591,000 | $14,727,000 | $12,293,000 | -$2,434,000 | 2016-02-16 |
|---|
| Q4 2015 | ACORDA THERAPEUTICS INC
CUSIP 00484M106 | | COM | 418,000 | 220,000 | -198,000 | $11,081,000 | $9,412,000 | -$1,669,000 | 2016-02-16 |
|---|
| Q4 2015 | SPECTRANETICS CORP
CUSIP 84760C107 | | COM | 624,000 | 586,000 | -38,000 | $7,357,000 | $8,825,000 | +$1,468,000 | 2016-02-16 |
|---|
| Q3 2015 | FTD COS INC
CUSIP 30281V108 | | COM | 458,000 | 186,000 | -272,000 | $12,911,000 | $5,543,000 | -$7,368,000 | 2015-11-16 |
|---|
| Q3 2015 | APOLLO ED GROUP INC
CUSIP 037604105 | | CL A | 1,270,000 | 880,000 | -390,000 | $16,358,000 | $9,733,000 | -$6,625,000 | 2015-11-16 |
|---|
| Q3 2015 | SKULLCANDY INC
CUSIP 83083J104 | | COM | 1,406,000 | 854,000 | -552,000 | $10,784,000 | $4,723,000 | -$6,061,000 | 2015-11-16 |
|---|
| Q3 2015 | INSPIREMD INC
CUSIP 45779A309 | | COM NEW | 6,560,000 | 6,500,000 | -60,000 | $1,837,000 | $1,073,000 | -$764,000 | 2015-11-16 |
|---|
| Q2 2015 | IGNYTA INC
CUSIP 451731103 | | COM | 1,780,000 | 870,000 | -910,000 | $17,711,000 | $13,128,000 | -$4,583,000 | 2015-08-14 |
|---|
| Q2 2015 | FEMALE HEALTH CO
CUSIP 314462102 | | COM | 1,126,000 | 600,000 | -526,000 | $3,187,000 | $1,080,000 | -$2,107,000 | 2015-08-14 |
|---|
| Q2 2015 | BLUCORA INC
CUSIP 095229100 | United States | COM | 774,000 | 700,000 | -74,000 | $10,573,000 | $11,305,000 | +$732,000 | 2015-08-14 |
|---|
| Q2 2015 | INSPIREMD INC
CUSIP 45779A309 | | COM NEW | 7,000,000 | 6,560,000 | -440,000 | $2,240,000 | $1,837,000 | -$403,000 | 2015-08-14 |
|---|
| Q1 2015 | RAPTOR PHARMACEUTICAL CORP
CUSIP 75382F106 | | COM | 800,000 | 130,000 | -670,000 | $8,416,000 | $1,413,000 | -$7,003,000 | 2015-05-15 |
|---|
| Q1 2015 | IAC INTERACTIVECORP
CUSIP 44919P508 | United States | COM PAR $.001 | 128,000 | 90,000 | -38,000 | $7,781,000 | $6,072,000 | -$1,709,000 | 2015-05-15 |
|---|
| Q1 2015 | QLOGIC CORP
CUSIP 747277101 | | COM | 642,000 | 468,000 | -174,000 | $8,551,000 | $6,898,000 | -$1,653,000 | 2015-05-15 |
|---|